Evidence map›Paper›PMID 2060181›Full record

ArticleClinical & experimental metastasis

Change in organotropism of mouse lymphoma variants associated with selective chemotactic responsiveness to organ-derived chemoattractants.

R Benke, V Schirrmacher

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

R BenkeInstitut für Immunologie und Genetik, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
V Schirrmacher

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A variant of the highly metastatic mouse lymphoma ESb was isolated from ESb suspension culture by repeated selection for adhesiveness to plastic. The adhesion variant ESb-MP was shown to have greatly reduced malignant potential and a change in organotropism. ESb-MP cells metastasized into the kidney with a high frequency (80% of mice), whereas the ESb cells only rarely infiltrated the kidney (4% of mice). Two subclones of the adherent variant (ESb-M2 A8, ESb-M2 H6) showed a reduced malignant potential in vivo very similar to the ESb-MP cell line, but only the clone ESb-M2 A8 infiltrated the kidney. Cell motility and chemotaxis of the various tumor lines was tested in a modified Boyden chamber assay. ESb-MP cells always migrated about 45 microns into a nitrocellulose filter of 8 microns pore size during 4 h incubation, whereas ESb cells and the two subclones migrated only to a distance of 12-25 microns. There was no apparent correlation between in vitro motility and malignancy in vivo. The addition of several factors known to be chemoattractant for granulocytes (C5a, FMLP) or for tumor cells (FMLP, laminin, fibronectin) did not affect the migration of ESb or ESb-MP cell lines. Enhanced migration of the ESb-MP cell line was, however, observed when kidney conditioned medium (KCM) was used as attractant in the lower chamber. This was not true for ESb cells. Additionally, within the subclones of the ESb-MP cell line, there was a remarkable correlation between kidney metastasis in vivo and responsiveness to KCM in vitro. The motility stimulating effect of KCM was due to a chemotactic activity. ESb cells, which did not respond to KCM, responded to other factor(s) derived from inflammatory exudate fluid. We conclude that the stimulation of tumor cell motility by an organotropic factor was highly selective for certain tumor lines. The correlation, between responsiveness in vitro and kidney metastasis in vivo, suggests that it is not so much the random migration of tumor cells which plays a role in metastasis but the motility following selective stimulation by tissue-derived factors and chemoattractants.

Indexed as

AnimalsCell MovementChemotactic FactorsInjections, SubcutaneousKidney NeoplasmsLymphomaMiceNeoplasm MetastasisNeoplasm TransplantationTumor Cells, CulturedChemotactic Factors

Identifiers

PMID2060181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.